Universe Pharmaceuticals (UPC) Competitors $1.79 -0.06 (-3.24%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends UPC vs. SXTC, CYTO, CWBR, TRVN, ADTX, ASLN, TFFP, ZVSA, ADXS, and QLGNShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include China SXT Pharmaceuticals (SXTC), Altamira Therapeutics (CYTO), CohBar (CWBR), Trevena (TRVN), Aditxt (ADTX), ASLAN Pharmaceuticals (ASLN), TFF Pharmaceuticals (TFFP), ZyVersa Therapeutics (ZVSA), Ayala Pharmaceuticals (ADXS), and Qualigen Therapeutics (QLGN). These companies are all part of the "pharmaceutical preparations" industry. Universe Pharmaceuticals vs. China SXT Pharmaceuticals Altamira Therapeutics CohBar Trevena Aditxt ASLAN Pharmaceuticals TFF Pharmaceuticals ZyVersa Therapeutics Ayala Pharmaceuticals Qualigen Therapeutics Universe Pharmaceuticals (NYSE:UPC) and China SXT Pharmaceuticals (NASDAQ:SXTC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Do insiders and institutionals believe in UPC or SXTC? 0.2% of Universe Pharmaceuticals shares are held by institutional investors. Comparatively, 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. 57.4% of Universe Pharmaceuticals shares are held by company insiders. Comparatively, 4.0% of China SXT Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is UPC or SXTC more profitable? Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A China SXT Pharmaceuticals N/A N/A N/A Does the media refer more to UPC or SXTC? In the previous week, Universe Pharmaceuticals had 3 more articles in the media than China SXT Pharmaceuticals. MarketBeat recorded 3 mentions for Universe Pharmaceuticals and 0 mentions for China SXT Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.20 beat China SXT Pharmaceuticals' score of 0.00 indicating that Universe Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Universe Pharmaceuticals Neutral China SXT Pharmaceuticals Neutral Which has stronger earnings and valuation, UPC or SXTC? China SXT Pharmaceuticals has lower revenue, but higher earnings than Universe Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$32.31M0.01-$6.16MN/AN/AChina SXT Pharmaceuticals$1.93M0.81-$3.10MN/AN/A Does the MarketBeat Community believe in UPC or SXTC? China SXT Pharmaceuticals received 82 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformUniverse PharmaceuticalsN/AN/AChina SXT PharmaceuticalsOutperform Votes8261.65% Underperform Votes5138.35% Which has more risk & volatility, UPC or SXTC? Universe Pharmaceuticals has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Comparatively, China SXT Pharmaceuticals has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. SummaryUniverse Pharmaceuticals beats China SXT Pharmaceuticals on 5 of the 9 factors compared between the two stocks. Ad Desko DigitalCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD! Get Your FREE Gold Investor Kit NOW! Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$430,000.00$6.58B$5.15B$20.02BDividend YieldN/A8.11%5.01%3.49%P/E RatioN/A11.01126.3243.41Price / Sales0.01363.551,231.8517.65Price / CashN/A52.5940.2921.28Price / Book0.0110.176.944.65Net Income-$6.16M$153.60M$119.61M$985.54M7 Day Performance1,173.12%2.65%0.99%2.60%1 Month Performance-66.76%-9.38%-4.26%2.57%1 Year Performance-88.18%28.29%31.27%26.28% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$1.79-3.2%N/A-89.0%$430,000.00$32.31M0.00225Stock SplitSXTCChina SXT PharmaceuticalsN/A$0.38flatN/A-77.8%$1.56M$1.93M0.0090CYTOAltamira Therapeutics0.5455 of 5 stars$0.44flatN/A-94.1%$1.49M$320,000.000.0020Gap DownCWBRCohBarN/A$0.50flatN/A-44.2%$1.46MN/A0.0010TRVNTrevena1.3923 of 5 stars$1.76+4.8%$5.00+184.6%-87.9%$1.45M$443,000.00-0.0440Analyst ForecastAnalyst RevisionGap UpADTXAditxt0.3394 of 5 stars$0.32-3.0%N/A-99.8%$1.37M$640,000.000.0047News CoverageASLNASLAN Pharmaceuticals1.1616 of 5 stars$0.60flat$76.00+12,566.7%N/A$1.23M$12M-0.0330TFFPTFF Pharmaceuticals1.6822 of 5 stars$0.35-5.4%$44.00+12,417.8%-95.0%$1.22M$730,000.00-0.0419Gap UpHigh Trading VolumeZVSAZyVersa Therapeutics2.3617 of 5 stars$1.14-0.9%$120.00+10,444.8%-95.7%$1.17MN/A0.002News CoverageADXSAyala PharmaceuticalsN/A$0.03-74.8%N/A-96.6%$1.15M$10,000.000.0020News CoverageGap DownQLGNQualigen TherapeuticsN/A$4.42+14.2%N/A-87.2%$1.11M$4.98M0.0050Gap Up Related Companies and Tools Related Companies SXTC Alternatives CYTO Alternatives CWBR Alternatives TRVN Alternatives ADTX Alternatives ASLN Alternatives TFFP Alternatives ZVSA Alternatives ADXS Alternatives QLGN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:UPC) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
